Palantir is a buy due to its critical AI software for military operations, accelerated adoption from current conflicts, and strong growth.
Source Post
3 Stocks To BUY NOW In March 2026
ZipTraderMar 3, 2026
The creator discusses how geopolitical conflict can create investment opportunities, particularly in defense stocks. They also highlight Medicus Pharma (MDCX) as a potential investment due to its non-surgical treatment for basal cell carcinoma.
Linked Mentions
Tickers discussed in this post
Medicus Pharma (MDCX) is a potential buy due to its novel non-surgical treatment for basal cell carcinoma.
Linked Signals
Tracked calls opened from this post
PLTR
buy opened Mar 3, 2026
+4.82%